Somaxon receives FDA feedback on Silenor OTC Regulatory Pathway
US-based Somaxon Pharmaceuticals has received FDA Feedback on Silenor OTC Regulatory Pathway.
Silenor is used for the treatment of insomnia characterized by difficulty with sleep maintenance.
According to the company, FDA provided clinical and regulatory guidance is believed to help develop an OTC label that is tailored to Silenor's clinical profile and differentiated from other OTC sleep products.
Silenor's characteristics, including its lack of addiction potential and its clinical efficacy and safety profile, make it an ideal candidate to be the first prescription insomnia product to be converted to an OTC product, the company claims.
Related Insight
Suppliers Directory
Production & Manufacturing
Fine & Speciality Chemicals
Manufacturing
Process & Production
OTC
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
OTC Intelligence
Buy the latest industry research online today!
UnitedHealth Group Incorporated: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report
ICD Research's "UnitedHealth Group Incorporated: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" is a crucial resource for industry executives and anyone looking to access key information about "UnitedHealth Group Incorporated" ICD Research's "UnitedHealth Group Incorporated: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $125
ICD Research's "UnitedHealth Group Incorporated: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" is a crucial resource for industry executives and anyone looking to access key information about "UnitedHealth Group Incorporated" ICD Research's "UnitedHealth Group Incorporated: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $125
Comments may be moderated for spam, obscenities or defamation.